Pediatrics
Feature
COVID emergency orders ending: What’s next?
There will be cost-sharing changes for COVID-19 vaccines, testing, and certain treatments.
Commentary
Managing respiratory symptoms in the ‘tripledemic’ era
Is it COVID-19, flu, or even RSV?
News
FDA okays Tidepool Loop app to help guide insulin delivery
Prescription-only device works with compatible continuous glucose monitors and insulin pumps for people with type 1 diabetes aged 6 years or older...
Commentary
Spikes out: A COVID mystery
A new study does a great job of...
News
FDA approves Wegovy (semaglutide) for obesity in teens 12 and up
FDA approves semaglutide 2.4mg (Wegovy), a once-weekly subcutaneous injection, for treating obesity in adolescents aged 12 years and older.
News
FDA okays Dexcom G7 continuous glucose monitoring system
The new version has several advantages over the G6, including smaller size, shorter warm-up time, and a 12-hour grace period before expiring.
News
With type 1 diabetes delay possible, focus now on screening
The FDA approval of teplizumab for the delay of type 1 diabetes highlights the need to cost effectively identify those at risk who could...
Latest News
Electrolyte disturbances a harbinger of eating disorders?
Electrolyte abnormalities were seen well ahead – more than a year – of the time when patients were diagnosed with eating disorders.
Feature
Younger doctors call for more attention to patients with disabilities
As the number of people with intellectual and developmental disabilities grows, medical educators look to the next generation of physicians to...
From the Journals
Myocarditis after COVID vax rare and mild in teens
Myocarditis in adolescents after Pfizer mRNA vaccination is rare with a mild and benign course and a favorable long-term prognosis, new data...
Conference Coverage
In epilepsy, heart issues linked to longer disease duration
Researchers hope to tease out mechanism of cardiovascular risk to improve monitoring and prevention.